Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
18,578,488
-
Total 13F shares
-
14,441,576
-
Share change
-
+4,849,086
-
Total reported value
-
$19,929,234
-
Price per share
-
$1.38
-
Number of holders
-
21
-
Value change
-
+$6,691,650
-
Number of buys
-
14
-
Number of sells
-
1
Institutional Holders of UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) as of Q1 2024
As of 31 Mar 2024,
UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,441,576 shares.
The largest 10 holders included
BVF INC/IL, RA CAPITAL MANAGEMENT, L.P., Vivo Capital, LLC, Rosalind Advisors, Inc., Monashee Investment Management LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, RENAISSANCE TECHNOLOGIES LLC, and CITADEL ADVISORS LLC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.